BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 25425534)

  • 1. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
    Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
    Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
    de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
    Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA; White CM; Wise PE; Herline AJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
    Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
    Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience.
    Guidi L; Ratto C; Semeraro S; Roberto I; De Vitis I; Papa A; Marzo M; Parello A; Foglietto G; Doglietto GB; Gasbarrini GB; Fedeli G
    Tech Coloproctol; 2008 Jun; 12(2):111-7. PubMed ID: 18545878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
    Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
    Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
    Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
    Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
    Regueiro M; Mardini H
    Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab and surgical treatment of complex anal Crohn's disease.
    Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ
    Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
    de Groof EJ; Buskens CJ; Ponsioen CY; Dijkgraaf MG; D'Haens GR; Srivastava N; van Acker GJ; Jansen JM; Gerhards MF; Dijkstra G; Lange JF; Witteman BJ; Kruyt PM; Pronk A; van Tuyl SA; Bodelier A; Crolla RM; West RL; Vrijland WW; Consten EC; Brink MA; Tuynman JB; de Boer NK; Breukink SO; Pierik MJ; Oldenburg B; van der Meulen AE; Bonsing BA; Spinelli A; Danese S; Sacchi M; Warusavitarne J; Hart A; Yassin NA; Kennelly RP; Cullen GJ; Winter DC; Hawthorne AB; Torkington J; Bemelman WA
    Trials; 2015 Aug; 16():366. PubMed ID: 26289163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment for complex fistulating perianal Crohn's disease.
    Antakia R; Shorthouse AJ; Robinson K; Lobo AJ
    Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particular aspects of proctology for anoperineal lesions in Crohn's disease.
    Atienza P; Ksiaa M
    J Visc Surg; 2015 Apr; 152(2 Suppl):S45-53. PubMed ID: 25687623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.